Yakov Kogan
Founder at STATERA BIOPHARMA, INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Fonstein | M | 64 |
Panacela Labs, Inc.
 Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY.
Integrated Genomics, Inc.
 Integrated Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Founded in 1997, Chicago-based Integrated Genomics™ specializes in research in microbial genomics, biochemistry, and gene expression. Its scientists has broad experience in both in silico and wet lab sequencing, research and development with more than 100 relevant publications in these areas. Integrated Genomics™ has particularly long-standing relationships and active research in the area of lactic acid bacteria and pathogenic microbes, as well as a broad customer base across industry, academic and government institutions. Integrated Genomics™' products and services are based on ERGO™, its web-based genome analysis platform. ERGO™ integrates proprietary functional genomic data, metabolic reconstructions, expression profiling, and biochemical and microbiological data with publicly available information. Focused on microbial genomics, ERGO™ provides better and faster identification of gene function across all organisms. In 2010 Integrated Genomics, Inc.'s business operations were transitioned to a new corporation, IG Assets, Inc. With the original Integrated Genomics' team, IG Assets continues to provide the same ERGO-based microbial genomic products and service. | 20 years |
| Christopher Zosh | M | 48 |
Panacela Labs, Inc.
Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY. | 10 years |
| Andrei V. Gudkov | M | 66 |
Genome Protection, Inc.
Panacela Labs, Inc.
Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY. | 21 years |
| C. Neil Lyons | M | 66 |
Panacela Labs, Inc.
Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY. | 13 years |
| Michael Handley | M | 52 | 3 years | |
| Joseph Frontiere | M | 34 | 3 years | |
| Leah Brownlee | F | - |
Panacela Labs, Inc.
Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY. | 14 years |
| Douglas Cole | M | 68 | 3 years | |
| James Mendolera | M | - | 13 years | |
| Derrick Chambers | M | 45 | 5 years | |
| Selby Blake Hawley | M | 59 | 2 years | |
| Uday Saxena | M | 66 | 2 years | |
| C. Satish Chandran | M | 68 | 2 years | |
| John A. Kallassy | M | 59 | 2 years | |
| Todd Headley | M | - | 3 years | |
| Robert W. Buckheit | M | 63 | 3 years | |
| Leysan Shaydullina | M | 45 |
Panacela Labs, Inc.
Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY. | 13 years |
| Peter M. Papasavas | M | - | - | |
| Dmitry Lisenkov | M | 48 |
Panacela Labs, Inc.
Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY. | 13 years |
| Allie Lopez | F | - | 4 years | |
| Curt Dewitz | M | - | 4 years | |
| George Wagner | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Randy Steven Saluck | M | 59 | 5 years | |
| Lea Verny | F | 59 | 1 years | |
| Julia Brown | F | 76 | 2 years | |
| Bernard Kasten | M | 77 | 7 years | |
| David Christian Hohn | M | 82 | 3 years | |
| Alexander Andryushechkin | M | 40 | 5 years | |
| Richard McGowan | M | 70 | 2 years | |
| Steve Barbarick | M | 56 | 1 years | |
| James Antal | M | 73 | 10 years | |
| Ekaterina E. Nikolaevskaya | F | 62 |
Panacela Labs, Inc.
Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY. | 4 years |
| Anna Evdokimova | F | 49 | 6 years | |
| Daniil Talyanskiy | M | 39 | 5 years | |
| Alexey Nechaev | M | 36 | 2 years | |
| Nichol Ochsner | M | - | - | |
| Elena Kasimova | F | - | - | |
| Taunia S. Markvicka | M | 56 | 1 years | |
| John Szydlo | M | 39 | - | |
| Langdon L. Miller | M | 70 | - | |
| Anthony Principi | M | 80 | - | |
| Ivan Fedyunin | M | 37 | 3 years | |
| Paul E. DiCorleto | M | 72 | 11 years | |
| Ivan Persiyanov | M | 44 | 4 years | |
| John A. Marhofer | M | 61 | 6 years | |
| H. Perez | M | 74 | 5 years | |
| Clifford A. Selsky | M | 76 | 1 years | |
| Julie M. Clifford | F | - | 1 years | |
| Cozette M. McAvoy | F | 45 | 1 years | |
| Natalia Khudyk | F | - | - | |
| Stephen Wilson | M | 54 | - | |
| Natalia Saraeva | F | - | - | |
| Tatiana Levina | F | - | - | |
| Robert Wilson | M | 51 | 2 years | |
| Konstantin Gorshkov | M | - | - | |
| Bani Tchekanova | F | - | - | |
| Ronald Demuth | M | - |
Integrated Genomics, Inc.
Integrated Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Founded in 1997, Chicago-based Integrated Genomics™ specializes in research in microbial genomics, biochemistry, and gene expression. Its scientists has broad experience in both in silico and wet lab sequencing, research and development with more than 100 relevant publications in these areas. Integrated Genomics™ has particularly long-standing relationships and active research in the area of lactic acid bacteria and pathogenic microbes, as well as a broad customer base across industry, academic and government institutions. Integrated Genomics™' products and services are based on ERGO™, its web-based genome analysis platform. ERGO™ integrates proprietary functional genomic data, metabolic reconstructions, expression profiling, and biochemical and microbiological data with publicly available information. Focused on microbial genomics, ERGO™ provides better and faster identification of gene function across all organisms. In 2010 Integrated Genomics, Inc.'s business operations were transitioned to a new corporation, IG Assets, Inc. With the original Integrated Genomics' team, IG Assets continues to provide the same ERGO-based microbial genomic products and service. | - |
| Yulia Lebedina | F | 45 | 1 years | |
| John Gordon | M | - | - | |
| Daniel F. Hoth | M | 78 | 1 years | |
| Peter J. Aronstam | M | 72 | 1 years | |
| Michael R. Kurman | M | 72 | - | |
| Jean Viallet | M | 66 | 1 years | |
| Ann Lenich Hards | M | - | - | |
| Farrel Fort | M | - | - | |
| Ed Venkat | M | - | - | |
| Judith Schnyder | F | - | - | |
| Michelle C. Ross | M | - | - | |
| Alexander Polinsky | M | 67 | - | |
| Donald Handley | M | - | - | |
| Michael Paterno | M | - | - | |
| Dmitry Prudnikov | M | 60 |
Panacela Labs, Inc.
Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY. | 3 years |
| Debra K. Bowes | F | - | 2 years | |
| Gillian Miller | M | - | - | |
| Cynthia Douglas | F | 51 | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 75 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Yakov Kogan
- Personal Network